I'd bet dollars to donuts that it's not January. There was
I'd bet dollars to donuts that it's not January. There was very little chance that it was ever going to be January. I have no idea why he continues to over promise and under deliver on timelines. What's the harm in just saying we'll have enough patients and data in Feb/March to submit? As long as we get there, ok, but I've been around long enough to know you just have to accept Nader-speak when it comes to time frames. Multiply Nader's stated timeline by 2.5 and you have the real answer.
For new investors, it can really damage credibility.
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Exploring Innovative Nonprofit Incubation Strategies by NVF Today, New Venture Fund has brought forth a significant report highlighting the nonprofit incubation process, titled "Growing Change: How New Venture Fund Incubates Nonprofits to Make Lasting Impact." This report sheds light on the intricacies of incubation, showcasing the essential characteristics of successful...
Continue Reading
Resolution of Legal Matters for Julio Herrera Velutini Following extensive and rigorous legal proceedings, Venezuelan-British banker, Julio Herrera Velutini, experienced a significant and favorable resolution in his legal case. This outcome follows more than three years of intense scrutiny regarding allegations against him, specifically targeting serious criminal charges....
Continue Reading
Growth Perspective on Height-Adjustable Desks The market for contemporary height-adjustable desks has been thriving, reflecting an expected increase of USD 2.75 billion by 2029. This surge is significantly driven by the growing demand for modern desks that promote better ergonomics in both office and home environments. This trend is part of a larger movement towards...
Continue Reading
Barnwell Industries Inc Stock Performance Review Barnwell Industries Inc (BRN) has recently encountered a challenging period, highlighted by its stock touching a 52-week low at $1.99. This significant decrease in stock value is alarming for investors and stakeholders alike. Over the past year, Barnwell's share price has plummeted by 21.48%, a clear indication of bearish...
Continue Reading
Innovative Approaches to Oncology at Altogen Labs Altogen Labs stands out as a premier preclinical research organization focused on propelling the field of oncology forward. They dedicate themselves to the innovative testing and evaluation of new treatments. With an emphasis on pharmacological and biological therapies, Altogen Labs aims to deliver groundbreaking...
Continue Reading
